Medartis Holding AG (SWX:MED)
Switzerland
· Delayed Price · Currency is CHF 66.40
+1.40 (2.15%)
Apr 10, 2025, 4:29 PM CET
Medartis Holding AG Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 224.83 | 212.01 | 182.82 | 159.88 | 127.65 | Upgrade
|
| Revenue Growth (YoY) | 6.05% | 15.96% | 14.35% | 25.25% | -1.92% | Upgrade
|
| Cost of Revenue | 46.15 | 44.43 | 33.34 | 25.77 | 21.15 | Upgrade
|
| Gross Profit | 178.68 | 167.57 | 149.49 | 134.11 | 106.5 | Upgrade
|
| Selling, General & Admin | 140.51 | 131.99 | 126.03 | 103.05 | 87.22 | Upgrade
|
| Research & Development | 25.24 | 25.91 | 25.33 | 20.05 | 16.17 | Upgrade
|
| Other Operating Expenses | 0.13 | - | - | - | - | Upgrade
|
| Operating Expenses | 165.87 | 157.9 | 151.36 | 123.09 | 103.4 | Upgrade
|
| Operating Income | 12.81 | 9.68 | -1.87 | 11.01 | 3.1 | Upgrade
|
| Interest Expense | -0.72 | -0.83 | -0.73 | -0.75 | -0.78 | Upgrade
|
| Interest & Investment Income | 1.33 | 0.34 | 0.25 | 0.14 | 0.37 | Upgrade
|
| Earnings From Equity Investments | 0.64 | -0.57 | -0.05 | 0.04 | 0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.11 | -4.55 | -3.19 | -1.43 | -5.39 | Upgrade
|
| Other Non Operating Income (Expenses) | -6.08 | -0.91 | -0.66 | -0.72 | -0.59 | Upgrade
|
| EBT Excluding Unusual Items | 8.08 | 3.15 | -6.25 | 8.29 | -3.26 | Upgrade
|
| Asset Writedown | -17.86 | - | - | - | - | Upgrade
|
| Legal Settlements | 0.6 | - | - | - | - | Upgrade
|
| Other Unusual Items | 6.88 | -1.36 | -0.9 | - | - | Upgrade
|
| Pretax Income | 2.5 | 1.79 | -7.15 | 8.29 | -3.26 | Upgrade
|
| Income Tax Expense | -1.03 | 1.17 | -1.36 | 1.45 | -2.32 | Upgrade
|
| Net Income | 3.53 | 0.62 | -5.78 | 6.84 | -0.94 | Upgrade
|
| Net Income to Common | 3.53 | 0.62 | -5.78 | 6.84 | -0.94 | Upgrade
|
| Net Income Growth | 469.95% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 12 | Upgrade
|
| Shares Change (YoY) | 1.10% | 3.69% | 0.29% | 0.27% | 0.24% | Upgrade
|
| EPS (Basic) | 0.29 | 0.05 | -0.49 | 0.58 | -0.08 | Upgrade
|
| EPS (Diluted) | 0.28 | 0.05 | -0.49 | 0.58 | -0.08 | Upgrade
|
| EPS Growth | 460.01% | - | - | - | - | Upgrade
|
| Free Cash Flow | 24.9 | 5.05 | -19.36 | 12.97 | 2.1 | Upgrade
|
| Free Cash Flow Per Share | 2.01 | 0.41 | -1.64 | 1.10 | 0.18 | Upgrade
|
| Gross Margin | 79.47% | 79.04% | 81.77% | 83.88% | 83.43% | Upgrade
|
| Operating Margin | 5.70% | 4.56% | -1.02% | 6.89% | 2.43% | Upgrade
|
| Profit Margin | 1.57% | 0.29% | -3.16% | 4.28% | -0.74% | Upgrade
|
| Free Cash Flow Margin | 11.07% | 2.38% | -10.59% | 8.11% | 1.65% | Upgrade
|
| EBITDA | 26.89 | 22.93 | 8.99 | 20 | 11.13 | Upgrade
|
| EBITDA Margin | 11.96% | 10.82% | 4.92% | 12.51% | 8.72% | Upgrade
|
| D&A For EBITDA | 14.08 | 13.25 | 10.86 | 8.98 | 8.03 | Upgrade
|
| EBIT | 12.81 | 9.68 | -1.87 | 11.01 | 3.1 | Upgrade
|
| EBIT Margin | 5.70% | 4.56% | -1.02% | 6.89% | 2.43% | Upgrade
|
| Effective Tax Rate | - | 65.48% | - | 17.51% | - | Upgrade
|
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.